BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15276667)

  • 1. Prevalence of induced mania in patients treated with milnacipran: a comparison with paroxetine.
    Morishita S; Arita S
    Eur Psychiatry; 2004 Aug; 19(5):315-6. PubMed ID: 15276667
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 3. Paroxetine-induced mania.
    Oldroyd J
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):721-2. PubMed ID: 9183122
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment.
    Sakakibara R; Ito T; Uchiyama T; Awa Y; Yamaguchi C; Hattori T
    Urol Int; 2008; 81(3):335-9. PubMed ID: 18931554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression.
    Morishita S; Arita S
    Eur Psychiatry; 2004 Nov; 19(7):450-1. PubMed ID: 15504656
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of milnacipran and paroxetine in outpatients with major depression.
    Sechter D; Vandel P; Weiller E; Pezous N; Cabanac F; Tournoux A;
    J Affect Disord; 2004 Dec; 83(2-3):233-6. PubMed ID: 15555719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran.
    Rahmadi M; Narita M; Yamashita A; Imai S; Kuzumaki N; Suzuki T
    Synapse; 2011 Jul; 65(7):652-7. PubMed ID: 21157932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.
    Yoshimura R; Mitoma M; Sugita A; Hori H; Okamoto T; Umene W; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1034-7. PubMed ID: 17459550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.
    Morishita S; Arita S
    Hum Psychopharmacol; 2004 Aug; 19(6):405-8. PubMed ID: 15303244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSRI-induced mania.
    Grubbs JH
    J Am Acad Child Adolesc Psychiatry; 1997 Apr; 36(4):445. PubMed ID: 9100415
    [No Abstract]   [Full Text] [Related]  

  • 12. Lower side effects of milnacipran than paroxetine in the treatment of major depression disorder among Han Chinese in Taiwan.
    Chang TT; Lêng CH; Wu JY; Lee SY; Wang YS; Chen YC; Lu RB
    Chin J Physiol; 2008 Dec; 51(6):387-93. PubMed ID: 19280883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's syndrome in a patient treated with milnacipran.
    Bourgade B; Jonville-Béra AP; Le Garé C; Ferquel D; Autret-Leca E
    Ann Pharmacother; 1999 Sep; 33(9):1009-10. PubMed ID: 10492510
    [No Abstract]   [Full Text] [Related]  

  • 14. Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.
    Kurose K; Hiratsuka K; Ishiwata K; Nishikawa J; Nonen S; Azuma J; Kato M; Wakeno M; Okugawa G; Kinoshita T; Kurosawa T; Hasegawa R; Saito Y
    Psychiatry Res; 2012 Aug; 198(3):424-9. PubMed ID: 22445761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of selective serotonin reuptake inhibitor-induced sexual dysfunction without worsening of depressive symptom after switching to milnacipran.
    Takahashi H; Ishigooka J
    Clin Neuropharmacol; 2009; 32(3):177-8. PubMed ID: 19483494
    [No Abstract]   [Full Text] [Related]  

  • 16. SSRI-induced mania in obsessive-compulsive disorder.
    Diler RS; Avci A
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):6-7. PubMed ID: 9893408
    [No Abstract]   [Full Text] [Related]  

  • 17. Mania associated with serotonin selective reuptake inhibitors.
    Vesely C; Fischer P; Goessler R; Kasper S
    J Clin Psychiatry; 1997 Feb; 58(2):88. PubMed ID: 9062382
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of severe antidepressant-induced nausea with a combination of milnacipran and olanzapine.
    Yoshida K; Higuchi H; Ozaki N
    Pharmacopsychiatry; 2007 Mar; 40(2):84-5. PubMed ID: 17447181
    [No Abstract]   [Full Text] [Related]  

  • 19. [Probable Serotonin Syndrome and Withdrawal Symptoms Caused by Milnacipran].
    Koshiishi T; Okuyama K
    Yakugaku Zasshi; 2016; 136(12):1675-1679. PubMed ID: 27904101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study.
    Patel R; Reiss P; Shetty H; Broadbent M; Stewart R; McGuire P; Taylor M
    BMJ Open; 2015 Dec; 5(12):e008341. PubMed ID: 26667012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.